A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients
Authors:
- Ahmed Abdel-RazikAAAhmed Abdel-Razik
- Nasser MousaNMNasser Mousa
- Walaa ShabanaWSWalaa Shabana
- Mohamed RefaeyMRMohamed Refaey
- Youssif ElMahdyYEYoussif ElMahdy
- Rania ElhelalyRERania Elhelaly
- Rasha ElzeheryRERasha Elzehery
- Khaled ZalataKZKhaled Zalata
- Mohammad ArafaMAMohammad Arafa
- Sherif ElbazSESherif Elbaz
- Mohamed HafezMHMohamed Hafez
- Mahmoud AwadMAMahmoud Awad
- 1 January 2016
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 28 (1) , e1-e9
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of progressive and chronic liver injury. Mean platelet volume (MPV) and the neutrophil-lymphocyte ratio (N/L ratio) may be considered cheap and simple markers of inflammation in many disorders. We aimed to investigate the clinical utility of MPV and the N/L ratio to predict fibrosis in NAFLD patients and the presence of nonalcoholic steatohepatitis (NASH). A total of 873 patients with biopsy-proven NAFLD and 150 healthy controls were included. Patients were divided into two groups: non-NASH group (n=753) and NASH group (n=120). Liver biopsy, MPV, lymphocyte, and neutrophil counts were registered; the N/L ratio was calculated. Proinflammatory cytokines (tumor necrosis factor-α and interleukin-6) were measured by an ELISA. NASH patients had higher MPV compared with non-NASH patients (10.9±1.8 and 9.5±1.6 fl, respectively, P<0.001). MPV correlated positively with the NAFLD activity score, proinflammatory cytokines, and C-reactive protein (CRP) (P<0.001). Patients with advanced fibrosis (F3-4) had increased MPV (11.3±0.9 fl) compared with patients with early fibrosis (F1-2) (10.2±0.8 fl, P<0.001). NASH patients had an increased N/L ratio compared with non-NASH cases (2.6±1.1 and 1.9±0.7 fl, respectively, P<0.001). The N/L ratio correlated positively with NAFLD activity score, proinflammatory cytokines, and CRP (P<0.001). In addition, patients with advanced fibrosis (F3-4) had an N/L ratio (2.5±1.1) comparable with that of patients with early fibrosis (F1-2) (1.8±0.9) (P<0.001). MPV and the N/L ratio were elevated in NASH patients versus non-NASH cases, and in patients with advanced fibrosis (F3-4) versus early fibrosis (F1-2). They can be used as noninvasive novel markers to predict advanced disease.Keywords
This publication has 41 references indexed in Scilit:
- Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinomaEuropean Journal of Cancer, 2012
- Mean platelet volume as an indicator of disease severity in patients with acute pancreatitisClinics and Research in Hepatology and Gastroenterology, 2012
- Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver diseaseUpsala Journal of Medical Sciences, 2010
- Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus NoninvasiveSeminars in Liver Disease, 2008
- Cytokeratin 18, a Marker of Cell Death, Is Increased in Children With Suspected Nonalcoholic Fatty Liver DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2008
- Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic SteatohepatitisAmerican Journal of Gastroenterology, 2008
- Non-alcoholic fatty liver disease: The mist gradually clearsJournal of Hepatology, 2008
- Clinical and Histologic Spectrum of Nonalcoholic Fatty Liver Disease Associated With Normal Alt ValuesHepatology, 2003
- Pathogenesis of steatohepatitisBest Practice & Research Clinical Gastroenterology, 2002
- Platelet size and age determine platelet function independentlyBlood, 1984